Drug profile · INN
bitolterol mesylate
TORNALATE
bitolterol mesylate (TORNALATE) is a beta-2 adrenergic receptor agonist. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — bitolterol mesylate
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
bitolterol mesylate (TORNALATE) is a beta-2 adrenergic receptor agonist. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is bitolterol mesylate?
bitolterol mesylate (TORNALATE) is a beta-2 adrenergic receptor agonist. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for bitolterol mesylate?
TORNALATE is a marketed brand name for bitolterol mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bitolterol mesylate?
bitolterol mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.